Try our Advanced Search for more refined results
CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al
Case Number:
2:19-cv-10099
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
April 07, 2020
Sun Pharma Must Face Celgene's Suit Over Generic Revlimid
Sun Pharma can't get out of Celgene's suit over a proposed generic version of the blockbuster cancer medication Revlimid, even though the patents in question aren't listed in the FDA's Orange Book, a New Jersey judge ruled Monday.
-
April 17, 2019
Celgene Wants Sun Pharma's Revlimid Generic Blocked
Celgene has asked a New Jersey federal court to stop Sun Pharma from moving forward with its generic version of the blockbuster cancer medication Revlimid until three patents expire.